Market Cap (In CNY)
3.7 Billion
Revenue (In CNY)
399.81 Million
Net Income (In CNY)
31 Million
Avg. Volume
12.68 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 7.48-16.13
- PE
- -
- EPS
- -
- Beta Value
- 0.746
- ISIN
- CNE100001575
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Yongming Zhang
- Employee Count
- -
- Website
- https://www.guanhaobio.com
- Ipo Date
- 2011-07-06
- Details
- Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicine in China. It offers NormalGEN, a type of biological dura repair patch manufactured from animal tissue; GrandNeuro, an artificial dura patch for dura repairing; ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; DermalGEN, a wound dressing product manufactured from animal tissue for use on burns, scalds, and wounds due to skin loss or trauma; and IREAL breast patch. The company was founded in 1999 and is based in Guangzhou, China.
More Stocks
-
VIPRF
-
BBTBoomBit S.A.
BBT
-
MYN
-
LDBLindbergh S.p.A.
LDB
-
SMNEYSiemens Energy AG
SMNEY
-
600724Ningbo Fuda Company Limited
600724
-
ONEGLOBALONE GLOBAL SERVICE PROVIDER LI
ONEGLOBAL
-
FAR